Projects per year
Fingerprint
Dive into the research topics where Klaus Podar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
JAK2 inhibitors and the innate immune response in mutant CALR-driven MPNs
Stoiber-Sakaguchi, D., Podar, K. & Kollmann, K.
Gesellschaft für Forschungsförderung NÖ
1/01/22 → 31/12/24
Project: Other
-
STAT3 isoforms in hematopoietic disorders
Stoiber-Sakaguchi, D., Podar, K. & Casanova, E.
Gesellschaft für Forschungsförderung NÖ
1/01/21 → 31/12/23
Project: Other
-
APOG: ACCESS POINT Oncology
Podar, K., Stoiber-Sakaguchi, D., Pecherstorfer, M., Georg, P. & Kieseberg, P.
Land NÖ - K3 (Abteilung Wissenschaft und Forschung)
1/01/20 → 31/12/23
Project: Other
-
Biomarker- based therapeutic prevention
Vallet, S., Podar, K. & Wiesner, C.
Gesellschaft für Forschungsförderung NÖ
1/12/19 → 1/12/22
Project: Other
-
JunB in multiple myeloma
Podar, K., Vallet, S., Lind, J., Czernilofsky, F., Kollmann, K. & Hundsberger, H.
Land NÖ - WST3 (Abteilung Wirtschaft, Tourismus amp Technologie)
1/10/18 → 30/09/22
Project: Other
Research output
-
Bone marrow microenvironment- induced regulation of Bcl-2 family members in multiple myeloma (MM): Therapeutic implications
Aksoy, O., Lind, J., Sunder-Plaßmann, V., Vallet, S. & Podar, K., Jan 2023, In: Cytokine. 161, p. 156062 156062.Research output: Journal article (peer-reviewed) › Journal article
Open Access -
Evaluation of Antibody Responses in Patients with B-Cell Malignancies after Two and Three Doses of Anti-SARS-CoV-2 S Vaccination—A Retrospective Cohort Study
Wirth, S. R. M., Podar, K., Pecherstorfer, M., Wohlfarth, P., Jaeger, U. & Singer, J., 14 Jan 2023, In: Cancers. 15, 2, p. 524Research output: Journal article (peer-reviewed) › Journal article
Open Access -
1255 Impact of immune checkpoint inhibitors on bone turnover in cancer patients: prospective clinical study and preclinical correlates
Gassner, T., Vallet, S., Chittilappilly, C., Pirich, T., Lind, J., Aksoy, O., Sunder-Plassmann, V., Hackner, K., Zwickl-Traxler, E., Errhalt, P., Pecherstorfer, M. & Podar, K., 2022, (Submitted) In: Journal for ImmunoTherapy of Cancer. p. A1300-A1300Research output: Journal article (peer-reviewed) › Conference contribution to journal
-
Ninreal - a Real World (RW) Comparison of Ixazomib Triplets and IMiD Duplets, in Relapsed and Refractory Multiple Myeloma (RRMM) from the Austrian Myeloma Registry (AMR)
Willenbacher, W., Pichler, P., Strassl, I., Krauth, M., Agis, H., Sormann, S., Hartmann, B. L., Podar, K., Weger, R. & Willenbacher, E., 15 Nov 2022, In: Blood. 140, Supplement 1, p. 13194-13195Research output: Journal article (peer-reviewed) › Journal article
-
On the continuous (R)evolution of antibody-based and CAR T cell therapies in multiple myeloma: an early 2022 glance into the future
Sunder-Plassmann, V., Aksoy, O., Lind, J., Pecherstorfer, M., Vallet, S. & Podar, K., 2022, In: Expert Opinion on Pharmacotherapy. 23, 12, p. 1425-1444 20 p.Research output: Journal article (peer-reviewed) › Review article